Molecule holds promise to reprogram white blood cells for better cancer treatment ...Middle East

Cancer immunotherapy using "designer" immune cells has revolutionized cancer treatment. In this type of therapy, T cells, a type of white blood cell, are collected from a patient's blood and genetically engineered to produce T cells carrying a synthetic molecule termed chimeric antigen receptor (CAR) that enables T cells to recognize and destroy cancer cells. Then these genetically modified CAR T cells are expanded and infused back to the patient.

Hence then, the article about molecule holds promise to reprogram white blood cells for better cancer treatment was published today ( Monday 14/12/2020 - 08:30 AM ) and is available on ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Molecule holds promise to reprogram white blood cells for better cancer treatment )

Also on site :

• If Kombucha’s the New Tequila, What’s Next for Alcohol Brands?
• Drew Barrymore’s ‘Charming’ New Under-$25 Sardine Home Collection at Walmart Is ‘Perfect for the Summertime’
• Three Iranian tankers exit U.S. blockade for first time in months as shipowners eye Hormuz in ‘wary disbelief’